Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma | Zendy

Ahmed Khattab | Zendy; Sunita Patruni | Zendy; Stephen Abel | Zendy; Shaakir Hasan | Zendy; Ethan B. Ludmir | Zendy; Gene Grant Finley | Zendy; Dulabh Monga | Zendy; Rodney E. Wegner | Zendy; Vivek Verma | Zendy

Open Access

Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma

Author(s) -

Ahmed Khattab,

Sunita Patruni,

Stephen Abel,

Shaakir Hasan,

Ethan B. Ludmir,

Gene Grant Finley,

Dulabh Monga,

Rodney E. Wegner,

Vivek Verma

Publication year - 2019

Publication title -

journal of gastrointestinal oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.084

H-Index - 39

eISSN - 2219-679X

pISSN - 2078-6891

DOI - 10.21037/jgo.2019.07.02

Subject(s) - medicine , chemotherapy , oncology , adenocarcinoma , neoadjuvant therapy , complete response , pancreatic ductal adenocarcinoma , general surgery , pancreatic cancer , cancer , breast cancer

Response of pancreatic adenocarcinoma to neoadjuvant chemotherapy (nCT) or chemoradiotherapy (nCRT) may be associated with prognosis, but long-term outcomes based on response to neoadjuvant therapy have not been well evaluated to date.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research